International Beneficence Clinical Research L L C is categorized under Medical Labs in Harlingen, TX .
International Beneficence Clinical Research L L C was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Jose Martin Hernandez at the company’s single location by writing to 913 East Harrison Avenue # 5, Harlingen, Texas TX 78550 or by phoning (956) 423-0045. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | International Beneficence Clinical Research L L C |
| Contact Person: | Jose Martin Hernandez |
| Address: | 913 East Harrison Avenue # 5, Harlingen, Texas 78550 |
| Phone Number: | (956) 423-0045 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
International Beneficence Clinical Research L L C was started in 0 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Jose Martin Hernandez for inquiries that concern International Beneficence Clinical Research L L C by calling the company number (956) 423-0045, as your correspondence is most welcome. Additionally, the physical location of the single location of International Beneficence Clinical Research L L C can be found at the coordinates as well as the street address 913 East Harrison Avenue # 5 in Harlingen, Texas 78550.
For its online presence, you may visit International Beneficence Clinical Research L L C’s website at and engage with its social media outlets through on Twitter and on Facebook.